Development and in silico validation of the PID-algorithm for the artificial pancreas with intraperitoneal insulin delivery

Background: The efficacy of the treatment of type 1 diabetes can be markedly improved using artificial pancreas (AP), which is a technology to automatically control blood glucose levels. Aim: In this paper, we propose the construction of a controller for controlling the automated delivery of insu...

Full description

Bibliographic Details
Main Authors: Vladimir A. Karpelyev, Yury I. Philippov, Artem V. Averin, Maxim D. Boyarsky, Dmitriy A. Gavrilov
Format: Article
Language:English
Published: Endocrinology Research Centre 2018-03-01
Series:Сахарный диабет
Subjects:
Online Access:https://dia-endojournals.ru/dia/article/viewFile/8265/7111
id doaj-bc4e861935e44709905fd92bbd72ef64
record_format Article
spelling doaj-bc4e861935e44709905fd92bbd72ef642021-06-02T19:24:42ZengEndocrinology Research CentreСахарный диабет2072-03512072-03782018-03-01211586510.14341/DM82658413Development and in silico validation of the PID-algorithm for the artificial pancreas with intraperitoneal insulin deliveryVladimir A. Karpelyev0Yury I. Philippov1Artem V. Averin2Maxim D. Boyarsky3Dmitriy A. Gavrilov4Endocrinology Research CentreEndocrinology Research CentreMoscow Institute of Physics and TechnologyEndocrinology Research CentreMoscow Institute of Physics and TechnologyBackground: The efficacy of the treatment of type 1 diabetes can be markedly improved using artificial pancreas (AP), which is a technology to automatically control blood glucose levels. Aim: In this paper, we propose the construction of a controller for controlling the automated delivery of insulin in AP based on a proportionalintegralderivative (PID) algorithm using intraperitoneal (IP) insulin delivery. Methods: The project used rapid-acting insulin in the IP space when setting up a PID controller with feedback to ensure the safe and efficient delivery of insulin. The controller was configured to satisfy feedback insulin present in blood. Controller check was performed In Silico using the metabolic simulator UVA|Padova T1DMS on 10 virtual patients. Results: The proposed controller design has time to reach 83% within the glycaemic range of 70140 mg/dl (3.97.8 mmol/l), without time spent in hypoglycaemia. Conclusions: In a future study we plan to test this controller in vivo to evaluate its performance in vivo.https://dia-endojournals.ru/dia/article/viewFile/8265/7111аrtificial pancreasintraperitoneal insulin infusionin silicocontrol algorithminsulin pumppreclinical studies
collection DOAJ
language English
format Article
sources DOAJ
author Vladimir A. Karpelyev
Yury I. Philippov
Artem V. Averin
Maxim D. Boyarsky
Dmitriy A. Gavrilov
spellingShingle Vladimir A. Karpelyev
Yury I. Philippov
Artem V. Averin
Maxim D. Boyarsky
Dmitriy A. Gavrilov
Development and in silico validation of the PID-algorithm for the artificial pancreas with intraperitoneal insulin delivery
Сахарный диабет
аrtificial pancreas
intraperitoneal insulin infusion
in silico
control algorithm
insulin pump
preclinical studies
author_facet Vladimir A. Karpelyev
Yury I. Philippov
Artem V. Averin
Maxim D. Boyarsky
Dmitriy A. Gavrilov
author_sort Vladimir A. Karpelyev
title Development and in silico validation of the PID-algorithm for the artificial pancreas with intraperitoneal insulin delivery
title_short Development and in silico validation of the PID-algorithm for the artificial pancreas with intraperitoneal insulin delivery
title_full Development and in silico validation of the PID-algorithm for the artificial pancreas with intraperitoneal insulin delivery
title_fullStr Development and in silico validation of the PID-algorithm for the artificial pancreas with intraperitoneal insulin delivery
title_full_unstemmed Development and in silico validation of the PID-algorithm for the artificial pancreas with intraperitoneal insulin delivery
title_sort development and in silico validation of the pid-algorithm for the artificial pancreas with intraperitoneal insulin delivery
publisher Endocrinology Research Centre
series Сахарный диабет
issn 2072-0351
2072-0378
publishDate 2018-03-01
description Background: The efficacy of the treatment of type 1 diabetes can be markedly improved using artificial pancreas (AP), which is a technology to automatically control blood glucose levels. Aim: In this paper, we propose the construction of a controller for controlling the automated delivery of insulin in AP based on a proportionalintegralderivative (PID) algorithm using intraperitoneal (IP) insulin delivery. Methods: The project used rapid-acting insulin in the IP space when setting up a PID controller with feedback to ensure the safe and efficient delivery of insulin. The controller was configured to satisfy feedback insulin present in blood. Controller check was performed In Silico using the metabolic simulator UVA|Padova T1DMS on 10 virtual patients. Results: The proposed controller design has time to reach 83% within the glycaemic range of 70140 mg/dl (3.97.8 mmol/l), without time spent in hypoglycaemia. Conclusions: In a future study we plan to test this controller in vivo to evaluate its performance in vivo.
topic аrtificial pancreas
intraperitoneal insulin infusion
in silico
control algorithm
insulin pump
preclinical studies
url https://dia-endojournals.ru/dia/article/viewFile/8265/7111
work_keys_str_mv AT vladimirakarpelyev developmentandinsilicovalidationofthepidalgorithmfortheartificialpancreaswithintraperitonealinsulindelivery
AT yuryiphilippov developmentandinsilicovalidationofthepidalgorithmfortheartificialpancreaswithintraperitonealinsulindelivery
AT artemvaverin developmentandinsilicovalidationofthepidalgorithmfortheartificialpancreaswithintraperitonealinsulindelivery
AT maximdboyarsky developmentandinsilicovalidationofthepidalgorithmfortheartificialpancreaswithintraperitonealinsulindelivery
AT dmitriyagavrilov developmentandinsilicovalidationofthepidalgorithmfortheartificialpancreaswithintraperitonealinsulindelivery
_version_ 1721401757948444672